Overview
Precision medicine is an approach to healthcare that tailors prevention, diagnosis, and treatment to the individual characteristics of each patient, integrating genomic, molecular, environmental, and lifestyle data rather than applying uniform interventions across a population. It rests on the recognition that disease arises and progresses through heterogeneous biological pathways, so therapies optimized for a defined molecular subtype can improve efficacy while reducing adverse effects. The field draws heavily on high-throughput technologies, including genomic sequencing, transcriptomics, and proteomics, which identify the variants, expression signatures, and protein markers that stratify patients into clinically meaningful groups. Biomarkers such as circulating microRNAs and immune-checkpoint protein status illustrate how molecular measurements can predict prognosis, guide drug selection, and monitor response over the course of treatment. Oncology has been a principal proving ground, where tumor profiling informs targeted and immunotherapeutic strategies, but the same logic extends to rheumatology, cardiology, and other specialties pursuing patient-stratified care. Increasingly, computational methods and artificial intelligence are used to integrate multi-omic and clinical datasets, while preclinical disease models support the safety and mechanistic evaluation that translation requires. Realizing precision medicine depends on robust data, analytical validity, and attention to equitable access across diverse patient populations.
Research published in this journal
6 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Towards Precision Rheumatology?
A Unifying Theory of Alzheimer’s and Other Neurodegenerative Diseases
Artificial Intelligence in Healthcare: Enhancing Efficiency, Ensuring Equity, and Restoring Empathy
A Role for in Vitro Disease Models in the Landscape of Preclinical Cardiotoxicity and Safety Testing
Dynamic MicroRNA-Expression in Plasma of Melanoma Patients Correlates With Progression, PD-L1 Status and Overall Survival
How this research is being cited
The 6 articles above have been cited 3 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Nov 2026.
-
2026 · Human Gene
-
2026 · Medical Sciences
-
A Role for in Vitro Disease Models in the Landscape of Preclinical Cardiotoxicity and Safety Testing2017 · Journal of Evolving Stem Cell Research
A sample of recent works citing this journal's research on Precision Medicine, linking to each citing work.